Antioxidant Assays
A working solution of 1000 µg/mL diluted from the stock was used in the screening assay. The antioxidant assays were followed from previous methods with some modifications as described below. 15 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid (ABTS) Assay ABTS radical was pre-formed from the overnight 1:1 chemical reaction of 15 mM ABTS and 5 mM potassium persulfate. The ABTS stock was diluted 1:50 with 5 mM PBS, pH 7.4 to obtain 50 mL ABTS working solution. In the assay, either Trolox standard solutions (10 µL), plant samples (10 µL) or 70% ethanol (10 µL) for controls were thoroughly mixed with ABTS working solution (290 µL) in assay wells. The microplate was subsequently incubated in the dark at 37°C for 6 minutes. All experiments were performed in triplicate. The absorbance was determined using a microplate reader, SpectraMax Plus 384 , Molecular Device Corporation, at 734 nm. Background absorbance was corrected by subtracting the absorbance value of blank (water/ 70% ethanol).
Diphenyl-Picryl Hydrazine (DPPH) Assay DPPH was diluted in 100% methanol at 0.24 mg/mL and allowed to settle overnight at 4°C. The stock was diluted at 1:5 with 50% methanol to obtain the DPPH working solution.15 µL each of Trolox standards, plant samples and solvents (water or 70% ethanol) as control wells were mixed with 285 µL of DPPH working solution in the assay wells. The 96 wells plate was incubated in the dark at 30 °C for 30 minutes. After incubation, the microplate was read at the wavelength of 517 nm using a microplate reader SpectraMax Plus 384 (Molecular Device Corporation). Background absorbance was corrected by subtracting the absorbance value of blank (water/ 70% ethanol).
The ABTS and DPPH percentage inhibition were calculated as: Percentage inhibition (%) = (1-(S/C)) x100; S=corrected absorbance value for sample and C=corrected absorbance value for control IC 50 Determination Samples with high antioxidant activities were prepared at lower concentrations to evaluate IC 50 value. The IC 50 value was determined from the best fitted line for each sample (R 2 ≈1.00).
Efficacy Test
Four of the 24 tested samples were selected for the efficacy test. The selection was based on the samples with IC 50 lower than Trolox standard in both assays to ensure the antioxidant activities exhibited were independent of the free radicals introduced. The selected actives were mixed with the base cream at 1%, 2% and 4% active: cream (w:w). The mixtures were allowed to settle overnight at 4°C. ABTS and DPHH assays were performed as described above. The cream base supplied consisted of mixtures of aqua, Helianthus annuus oil, cetyl alcohol, glycerin, Cocos nucifera oil, PEG-100 stearate, cetearyl alcohol, Prunus amygdalus oil, Simmondsia chinensis, Theobroma cacao butter, Chondrus crispus, benzyl alcohol, phenoxyethanol, potassium sorbate and tocopherol. The final concentration of the active at 1, 2 and 4% formulation in the ABTS assay were 1.3 µg/mL, 2.6 µg/mL and 5.2 µg/mL. The final assay concentration of the active at similar percentage formulations in the DPPH assay were 2 µg/mL, 4 µg/mL and 8 µg/mL. For comparison, sample alone at similar concentration for each formulation was investigated.
Statistical Analysis ANOVA was used to compare the mean differences between samples and P < 0.05 was considered as significant.
Results

Screening
Significantly high antioxidant activities were observed with the following extracts/ compounds; amla extract, bearberry extract, ellagic acid, green tea with 90% EGCG, kakadu plum extract, mango extract, pomegranate extract, resveratrol, Rhodiola rosea extract, tetrahydrocurcuminoid and oleuropein 40%), whereas low to intermediate antioxidant activities were observed for: Centella asiatica whole extract, Centella asiatica with 2% asiaticoside and Moringa oleifera leaf extract' and low to no activity for fucoidan, nobiletin, galangal extract, kojic acid dipalmitate, niacinamide, pullulan, sea buckthorn oil, aloe extract, L-carnosine and willow bark extract ( Table 1) .
Comparison of IC 50 (ABTS and DPPH Assay) Ten samples with 80-90 % radical's inhibitions for both assays (amla extract, bearberry extract, ellagic acid, green tea with 90% EGCG, kakadu plum extract, mango extract, pomegranate extract, resveratrol, Rhodiola rosea extract and tetrahydrocurcuminoid) were evaluated for potency. In Figure 1 , samples labelled 1, 2, 3, and 4 (amla extract, green tea extract, mango extract and pomegranate extract) had higher potency, observed from lower IC 50 than Trolox standard in both assays. The four samples were further evaluated for efficacy in cream matrices.
Efficacy Test (1%, 2% and 4% Active: Cream Formulation) 1% Formulation. Figure 2 shows significant increase in antioxidant activities for mango extract mixed with cream in both assays. However, green tea and pomegranate extract in cream had a decrease in activities in both The samples were grouped into high, low-intermediate and low to no activities. The samples were tested at 1000 µg/ mL with final concentrations of 3.3 and 2.0 µg/mL for ABTS and DPPH assay respectively. High = 80%-90% inhibition, low-intermediate = 10-50 % and low-no activity = below 10%. Data are mean ± SD (n = 4). assays. Trolox and amla extract were either retained or had increase in antioxidant activities in the formulation. 2% Formulation. In a 2% formulation (Figure 3 ), Trolox standard retained its activity, but green tea had lower activity when mixed with cream in both assays. Amla, mango and pomegranate extract retained their activities in only one assay. Mango extract had significantly higher antioxidant activity when in cream, while amla and pomegranate had lower antioxidant activities when in cream. 4 % Formulation. In a higher percentage formulation, mango extract consistently had higher antioxidant activities in both assays (Figure 4) , while Trolox and amla extracts retain their activities. Green tea with 90% EGCG and pomegranate extracts were not included at 4% formulation because the assay's limit was reached for both samples based on their IC 50 value ( Figure 1 ).
Discussion
Common approaches in the cosmetic product development focus on the inclusion of "actives", such as botanical extracts or pure compounds in the product formulation with intended effects to promote healthy skin and/or manage the characteristics of aged skin. Actives, such as antioxidants are believed capable of diminishing the oxidative damages caused by free radicals, potentially by restoring the balance between endogenous antioxidants and the oxidants. 7, 9, 16 In this study, we demonstrated that botanical extracts possessed high antioxidant capacities as pure compounds (resveratrol and tetrahydrocurcuminoid) ( Table 1) . However, some of the extracts (Centella asiatica, Moringa oleifera, galangal, willow bark, aloe, fucoidan, sea buckthorn oil) had low or no activity, may be due to the extraction methods used to prepare the samples. [17] [18] [19] [20] The other samples may not be active as antioxidants, such as kojic acid dipalmitate and nobiletin which are being used as skin whitening agents, 21, 22 niacinamide as anti-bacterial and anti-inflammatory 23 and pullulan as a natural polymer 4
Efficacy of extracts used in skin care products to enhance delivery of drugs or cosmetic agents. 24 Comparison of sample's potency, expressed as IC 50 (Figure 1 ), showed four samples (amla, green tea, mango, pomegranate) to have lower IC 50 compared with Trolox in both assays. Of the 4 samples, we demonstrated that the mango extract in the cosmetic formulation exhibited a consistent synergistic interaction with the other ingredients in the cream base. Mango extracts has been shown to have protective effects against skin aging by being able to reduce wrinkle formation and increase collagen bundle. 25 With an enhance activity in cream formulation, the use of mango extract in this formulation will ensure the ability of the product to retain claimed effect. Although, the mechanisms involved is unclear, its active compound (mangiferin, anthocyanin and carotenoids) were postulated to exert synergism. 26, 27 Similar synergistic effect, respective to the combinations, was observed in a study investigating synergistic antioxidant effects of fruits, vegetables and legumes extracts. 28 However, antagonisms effect may also occur within a formulation. Green tea and pomegranate were observed to have significant reduction at almost all percentage formulation. The observed results suggest antagonistic effect or instability of the extracts within the formulation. For example, green tea was found to be pH-dependent, where the green tea and its component were unstable and easily degraded in alkaline solution than in acidic solution. 29, 30 Evaluation the potential interactions between ingredients in a cosmetic formulation is a critical aspect to ensure product efficacy.
Conclusion
This study provided information on the antioxidant activities of commonly used extracts/compounds and the potential interaction between ingredients in a cosmetic formulation. However, the reported activities of synergism or antagonism between the studies extracts were respective to the cream ingredients.
